|
Figure 3
The conformational issues that can arise in interpreting a crystal energy landscape of a flexible pharmaceutical GSK269984B (XI): (a) overlay of the ab initio optimized isolated molecule conformation (red) with the conformations in all the crystal structures obtained in an extensive experimental screen guided by the crystal energy landscape (Ismail et al., 2013 ![]() ![]() |